Serum parathyroid hormone is a new potential risk factor in multiple myeloma

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Kang, Min Gu ^a   Won, Eun Jeong ^a   Choi, Hyun Woo ^a   Kim, Hye Ran ^b   Choi, Hyun Jung ^a   Park, Hye Ri ^a   Shin, Jong Hee ^a   Suh, Soon Pal ^a   Ryang, Dong Wook ^a   Shin, Myung Geun ^a  

^a Chonnam National University Medical School   (South Korea)

^b NATIONAL CANCER INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; CALCIUM; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FREE LIGHT CHAIN LAMBDA; IMMUNOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; INTERLEUKIN 6; LACTATE DEHYDROGENASE; MELPHALAN; PARATHYROID HORMONE; PREDNISONE; THALIDOMIDE; UNCLASSIFIED DRUG; VINCRISTINE; TUMOR MARKER;

ADULT; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIUM BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER DIAGNOSIS; CANCER PROGNOSIS; CANCER REGRESSION; CANCER STAGING; CANCER TRANSPLANTATION; CELL MIGRATION; CELL SURVIVAL; FEMALE; FOLLOW UP; HAZARD RATIO; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOGLOBULIN BLOOD LEVEL; LACTATE DEHYDROGENASE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; METASTASIS; MULTIPLE MYELOMA; OVERALL SURVIVAL; PARATHYROID HORMONE BLOOD LEVEL; PROGRESSION FREE SURVIVAL; RISK FACTOR; STEM CELL NICHE; TUMOR GROWTH; AGED; BLOOD; DISEASE FREE SURVIVAL; MORTALITY; SURVIVAL RATE;

ADULT; AGED; DISEASE-FREE SURVIVAL; FEMALE; HUMANS; MALE; MULTIPLE MYELOMA; PARATHYROID HORMONE; RISK FACTORS; SURVIVAL RATE; TUMOR MARKERS, BIOLOGICAL;

EID: 84902277270     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/804182     Document Type: Article

References (13)

1. Pirih F. Q., Michalski M. N., Cho S. W., Koh A. J., Berry J. E., Ghaname E., Kamarajan P., Bonnelye E., Ross C. W., Kapila Y. L., Jurdic P., McCauley L. K., Parathyroid hormone mediates hematopoietic cell expansion through interleukin-6. PLoS ONE 2010 5 10 2-s2.0-78149461750 10.1371/journal.pone. 0013657 e13657
2. Adams G. B., Martin R. P., Alley I. R., Chabner K. T., Cohen K. S., Calvi L. M., Kronenberg H. M., Scadden D. T., Therapeutic targeting of a stem cell niche. Nature Biotechnology 2007 25 2 238 243 2-s2.0-33846869023 10.1038/nbt1281
3. Zhang J., Niu C., Ye L., Osteoblastic cells regulate the haematopoietic stem cell niche. Nature 2003 425 6960 836 841
4. Ballen K. K., Shpall E. J., Avigan D., Yeap B. Y., Fisher D. C., McDermott K., Dey B. R., Attar E., McAfee S., Konopleva M., Antin J. H., Spitzer T. R., Phase I trial of parathyroid hormone to facilitate stem cell mobilization. Biology of Blood and Marrow Transplantation 2007 13 7 838 843 2-s2.0-34250203595 10.1016/j.bbmt.2007.03.007
5. Pest E. P., McQuaker G., Hunter J. A., Moffat D., Stanley A. J., Primary hyperparathyroidsm, amyloid and multiple myeloma: an unusual association. Scottish Medical Journal 2005 50 1 32 34 2-s2.0-15844394505
6. Greenfield E. M., Horowitz M. C., Lavish S. A., Stimulation by parathyroid hormone of interleukin-6 and leukemia inhibitory factor expression in osteoblasts is an immediate-early gene response induced by cAMP signal transduction. Journal of Biological Chemistry 1996 271 18 10984 10989
7. Treon S. P., Anderson K. C., Interleukin-6 in multiple myeloma and related plasma cell dyscrasias. Current Opinion in Hematology 1998 5 1 40 48 2-s2.0-0031911838
8. Arnulf B., Bengoufa D., Sarfati E., Toubert M.-E., Meignin V., Brouet J.-C., Fermand J.-P., Prevalence of monoclonal gammopathy in patients with primary hyperparathyroidism: a prospective study. Archives of Internal Medicine 2002 162 4 464 467 2-s2.0-0037169967
9. Kyle R. A., Rajkumar S. V., Criteria for diagnosis, staging, risk stratification and response assessment of multiple myeloma. Leukemia 2009 23 1 3 9 2-s2.0-58249097191 10.1038/leu.2008.291
10. Shiozawa Y., Pedersen E. A., Havens A. M., Jung Y., Mishra A., Joseph J., Kim J. K., Patel L. R., Ying C., Ziegler A. M., Pienta M. J., Song J., Wang J., Loberg R. D., Krebsbach P. H., Pienta K. J., Taichman R. S., Human prostate cancer metastases target the hematopoietic stem cell niche to establish footholds in mouse bone marrow. The Journal of Clinical Investigation 2011 121 4 1298 1312 2-s2.0-79953331206 10.1172/JCI43414
11. Palumbo A., Anderson K., Multiple myeloma. The New England Journal of Medicine 2011 364 11 1046 1060 2-s2.0-79952781038 10.1056/NEJMra1011442
12. Ghobrial I. M., Myeloma as a model for the process of metastasis: implications for therapy. Blood 2012 120 1 20 30
13. Pennisi A., Ling W., Li X., Khan S., Wang Y., Barlogie B., Shaughnessy J. D. Jr., Yaccoby S., Consequences of daily administered parathyroid hormone on myeloma growth, bone disease, and molecular profiling of whole myelomatous bone. PLoS ONE 2010 5 12 2-s2.0-78650875646 10.1371/journal.pone.0015233 e15233